Duhay Francis 4

What Happened

• Duhay Francis, a director of enVVeno Medical Corp (NVNO), sold 140 shares in an open-market transaction on March 12, 2026. The sale was reported at a weighted-average price of $11.52 per share for a total proceeds of approximately $1,613. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-03-12; filing date: 2026-03-13 (filed timely).
• Shares sold: 140; weighted-average price: $11.52; total proceeds: ~$1,613.
• Execution detail: trade executed in multiple trades at prices from $11.5200 to $11.5450 (footnote F2). Reporting person can provide full per-trade details upon request.
• Planned sale: completed under a Rule 10b5-1 trading plan adopted by the reporting person in June 2025 (footnote F1).
• Shares owned after the transaction: not specified in the supplied filing excerpt.

Context

• This was a pre-planned sale under a 10b5-1 plan, which typically means trades were made according to a previously established schedule rather than timed to recent company news. Sales are common and do not, by themselves, indicate an insider's negative view of the company.